Protective effect of aspirin against dexamethasone-induced cataract in cultured rat lens

Ophthalmic Research

Volumn 38, Issue 5, 2006, Pages 303-308

  Yan, Hong ^a   Wang, Jianwei ^a   Liu, Bing ^a   Shang, Lijun ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aspirin; Catalase; Lactate dehydrogenase; Steroid induced cataract; Superoxide dismutase

Indexed keywords

ACETYLSALICYLIC ACID; CATALASE; DEXAMETHASONE; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CELL JUNCTION; CELL MEMBRANE; CELL ORGANELLE; CELL VACUOLE; CONTROLLED STUDY; DISSECTION; ENZYME ACTIVITY; EYE PROTECTION; IN VITRO STUDY; INCUBATION TIME; LENS; LENS EPITHELIUM; LENS FIBER; LENS NUCLEUS; MICROSCOPE; MITOCHONDRION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; SUPERNATANT; ULTRASTRUCTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CATALASE; CATARACT; DEXAMETHASONE; L-LACTATE DEHYDROGENASE; LENS, CRYSTALLINE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 33745912320     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095774     Document Type: Article

References (32)

1. Cumming RG, Mitchell P, Leader SR: Inhaled corticosteroids and the risk of cataract. N Engl J Med 1997;337:1555.
2. Garbe E, Suissa S, LeLorier J: Association of inhaled corticosteroid use with cataract extraction in elderly patients. J Am Med Assoc 1998;280:539-543.
3. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999;33:829-839.
4. Ng JS, Wong W, Law RW, Hui J, Wong EN, Lam DS: Ocular complications of paediatric patients with nephritic syndrome. Clin Exp Ophthalmol 2001;29:239-243.
5. Jobling AI, Augusteyn RC: What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002;85:61-75.
6. Creighton MO, Sanwal M, Stewart-DeHaan PJ, Trevithick JR: Modeling cortical cataractogenesis. V. Steroid cataracts induced by solumedrol partially prevented by vitamin E in vitro. Exp Eye Res 1983;37:65-76.
7. Hook DWA, Harding JJ: Alpha-crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation. FEBS Lett 1996;382:281-284.
8. Hook DWA, Harding JJ: Inactivation of glyceraldehyde 3-phosphate dehydrogenase by sugars, prednisolone 21-hemisuccinate, cyanate and other small molecules. Biochim Biophys Acta 1997;1362:232-242.
9. Yan H, Harding JJ: Inactivation and loss of antigenicity of esterase by sugars and a steroid. Biochim Biophys Acta 1999;1454:183-190.
10. Bucala R, Gallati M, Manabe S, Cotlier E, Cerami A: Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp Eye Res 1985;40:853-863.
11. Jobling AI, Stevens A, Augusteyn RC: Binding of dexamethasone by alpha-crystallin. Invest Ophthalmol Vis Sci 2001;42:1829-1832.
12. Hook DWA, Harding JJ: The effect of modification of alpha-crystallin by prednisolone-21-hemisuccinate and fructose 6-phosphate on chaperone activity. Dev Ophthalmol 2002;35:150-160.
13. Ohta Y, Okada H: Partial reversal of methylprednisolone-induced opacity in isolated rat lenses. Ophthalmic Res 2002;34:128-134.
14. Lyu J, Kim JA, Chung SK, Kim KS, Joo CK: Alteration of cadherin in dexamethasone-induced cataract organ-cultured rat lens. Invest Ophthalmol Vis Sci 2003;44:2034-2040.
15. Nagai K, Sasaki H, Kojima M, Sasaki K: An alternative method of steroid-induced lens opacification in brown norway rat eyes applying systemic pulse administration. Ophthalmic Res 2004;36:231-236.
16. Gilroy DW, Perretti M: Aspirin and steroids: new mechanistic findings and avenues for drug discovery. Curr Opin Pharmacol 2005;5:405-411.
17. Cotlier E, Sharma YR: Aspirin and senile cataracts in rheumatoid arthritis. Lancet 1981;1:338-339.
18. Harding JJ: Can drugs or micronutrients prevent cataract? Drugs Aging 2001;18:473-486.
19. Harding JJ: Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev 2002;1:465-479.
20. Mathur P, Gupta SK, Wegener AR, Breipohl W, Ahrend MH, SharmaYD, Gupta YK, Vajpayee RB: Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro. Curr Eye Res 2000;21:926-933.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Yan H, Harding JJ: Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 1997;328:599-605.
23. Yan H, Harding JJ, Hui YN, Li MY: Decreased chaperone activity of alpha-crystallin in selenite cataract may result from selenite-induced aggregation. Eye 2003;17:637-645.
24. Sun Y, Oberley LW, Ying LA: Simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
25. Thomson JF: The use of deuterated DPNH mixtures as an aid in establishing dehydrogenase mechanism. Biochemistry 1963;2:224-228.
26. Lou MF: Redox regulation in the lens. Exp Ery Res 2003;22:657-682.
27. Nagpal RC, Singh RC, Singh GP, Ahluwalia BK: Total lactate dehydrogenase and its isoenzyme pattern in lens, aqueous humour, and serum in cases of senile cataract. Acta Ophthalmol (Copenh) 1991;69:57-60.
28. Nishigori H, Lee JW, Iwatsuru M: Glucocorticoid-induced cataract of the developing chick embryo-prevention by propylene glycol. Ophthalmic Res 1995;27:350-354.
29. Watanabe H, Kosano H, Nishigori H: Steroid-induced short term diabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation. Invest Ophthalmol Vis Sci 2000;41:1846-1852.
30. Kilic F, Trevithick JR: Modelling cortical cataractogenesis. XXIX. Calpain proteolysis of lens fodrin in cataract. Biochem Mol Biol Int 1998;45:963-978.
31. Bantseev VL, Herbert KL, Trevithick JR, Sivak JG: Mitochondria of rat lenses: distribution near and at the sutures. Curr Eye Res 1999;19:506-516.
32. Woollard AC, Wolff SP, Bascal ZA: Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract. Free Radic Biol Med 1990;9:299-305.